Prudential Financial Inc Kronos Bio, Inc. Transaction History
Prudential Financial Inc
- $67.5 Billion
- Q1 2025
A detailed history of Prudential Financial Inc transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 35,400 shares of KRON stock, worth $24,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,400
Previous 55,800
36.56%
Holding current value
$24,072
Previous $53,000
45.28%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KRON
# of Institutions
48Shares Held
19.3MCall Options Held
51.2KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$1.88 Million44.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.31 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$985,0840.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$977,9970.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$969,0440.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $38.6M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...